Depression level and quality of life in ovarian cancer patients in Zainoel Abidin Hospital, Banda Aceh
Downloads
Objectives: to determine the relationship between depression and quality of life in ovarian cancer patients who are undergoing chemotherapy in RSUDZA Banda Aceh.
Materials and Methods: This study was an analytical observa-tional study with cross-sectional design approach. The samples were taken by using accidental sampling with total of respondents are 30 patients. Depression level was assessed by using the BDI-II questionnaire and quality of life was assessed by using the EORTC QLQ-C30 questionnaire. Then, data were analyzed by using Spearman's Correlation test.
Results: The most of the cases were no depression (53,3%), and good quality of life (56,7%). The lowest cases were patients with severe depression (6,7%), and poor quality of life (16,7%). The results of data analysis obtained p value=0.000 (p≤0,05). Conclusion: there is a significant relationship between depression and quality of life in ovarian cancer patients who are undergoing chemotherapy in RSUDZA Banda Aceh.Siegel R, Naishadham D, Jemal A. Cancer Statistics. CA: A Cancer Journal for Clinicians. 2012; 62:5.
Gupta D, Braun DP, Staren ED, Markman M. Longitudinal health-related quality of life assess-ment: Implications for prognosis in ovarian cancer. Journal of Ovarian Research 2013;6-17.
Ferlay J, Soerjomataram I, Ervik M, et al. GLOBO-CAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. [serial on the Internet]; 2013. [cited 2016 March 22]. Lyon, France: International Agency for Research on Cancer. Available from: http:// globocan.iarc.fr
Cancer Research UK. Ovarian cancer incidence statistics. [serial on the Internet]; 2016. [cited 2016 March 22]. Available from: http://www.cancer researchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/ovarian-cancer/incidence#heading-Zero
Trihandini I, Nurrika D. Analisis ketahanan hidup lima tahun penderita kanker ovarium epithelial di Rumah Sakit Kanker Dharmais Jakarta. Jurnal Kesehatan Masyarakat Nasional. 2010;5:140.
Kementerian Kesehatan RI. InfoDATIN Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta; 2015;5.
RSUDZA. Rekam Medik Ruang Rawat Inap Serune 3 dan Mamplam 3. Banda Aceh; 2015.
Gonçalves V, Jayson G, Tarrier NA. Longitudinal investigation of posttraumatic stress disorder in patients with ovarian cancer. Journal of Psycho-somatic Research 2011;70(5):422-31.
Hess LM, Stehman FB. State of the science in ovarian cancer quality of life research: a systematic review. International Journal of Gynecological Cancer 2012;22(7);1273-80.
Chase DM, Wenzel L. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Review of Pharmaco-econo-mics and Outcomes Research. 2011;11(4): 421-31.
Gonçalves, V. Quality of life in ovarian cancer survivors. Journal Research and Networks in Health 2015;2-6.
Perbowo P, Askandar B, Sunjoto, Soebadi RD, Basori A. Perbandingan Kejadian Neutropeni dan Neuropati Perifer Akibat Kemoterapi Adjuvan Paclitaxel – Carboplatin antara Paclitaxel Infus 3 Jam dengan Paclitaxel Infus 24 Jam pada Penderita Kanker Ovarium Stadium I–IV. Majalah Obstetri dan Ginekologi 2008;16:108-9.
Kim SI, Lee Y, Lim MC, et al. Quality of life and sexuality comparison between sexually active ovarian cancer survivors and healthy women. Journal of Gynecologic Oncology 2015;148-54.
Purdie DM, Bain CJ, Siskind V, et al. Ovulation and risk of epithelial ovarian cancer. Int J Cancer. 2003;104(2):228-32.
Sun CC, Ramirez PT, Bodurka DC. Quality of life for patients with epithelial ovarian cancer. Nature Clinical Practice Oncology 2007;4(1):18-29.
Bevers DB, Engquisth KB, Carmack CL, Fitzgerald MA, Wolf JK, et al. Depression, Anxiety, and Quality of Life in Patients with Epihelial Ovarian Cancer. Gynecologic Oncology. 2002;78(3):302-8.
Matulonis UA, Kornblith A, Lee H, et al. Long-term adjusment of early-stage ovarian cancer survivors. International Journal of Gynecological Cancer 2008;18(6):1183-93.
Teng FF, Kalloger SE, Brotto L, McAlpine JN. Detereminants of quality of life in ovarian cancer survivors: a pilot study. Journal of Obstetrics and Gynecology Canada 2014;36(8):708-15.
Halim, Surjaningsih M. Efek terapi terhadap quality of life penderita kanker ginekologi. Tesis. Jakarta: Universitas Atma Jaya, Fakultas Psikologi; 2004.
Sutrisno H, Dharmayuda TG, Rena RA. Gambaran kualitas hidup pasien kanker limfoma non hodgkin yang dirawat di RSUP Sanglah Denpasar. Jurnal Penyakit Dalam 2010;11(2):98.
Dehkordi A, Heydarnejad MS, Fatehi D. Quality of life in cancer patients undergoing chemotherapy. Oman Medical Journal 2009;24(3).
Sood AK, Bhatty R, Kamat AA, et al. Stress hormone mediated invasion of ovarian cancer cells. Journal of American Association for Cancer Research 2006;12(2).
Moreno-Smith M, Lu C, Shahzad MM, et al. dopamine block stress-mediated ovarian carcinoma growth. Clin Cancer Res. 2011;17(11):3649-59.
Basyar R, Sanif R. Terapi antiangiogenik pada kanker ovarium. palembang: Departemen Obstetri dan Ginekologi, Fakultas Kedokteran Universitas Sriwijaya 2014.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
